Ono Pharmaceutical Co Ltd 2021 Sustainability Report
The report describes ONO's FY2020 environmental performance, including 26.1 kt-CO2 of market-basis Scope 1 and 2 emissions and a 13.2% renewable-energy share. It reports progress against SBTi-approved 1.5°C targets and TCFD-aligned climate disclosures. The report also covers employee development, including 34.1 annual training hours per employee, and reproduces Deloitte Tohmatsu Sustainability's limited assurance report over selected sustainability data.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2021
Type: Sustainability Report
Pages: 160
Back to company
Ono Pharmaceutical Co Ltd
CSR Report
The report describes ONO's FY2020 environmental performance, including 26.1 kt-CO2 of market-basis Scope 1 and 2 emissions and a 13.2% renewable-energy share. It reports progress against SBTi-approved 1.5°C targets and TCFD-aligned climate disclosures. The report also covers employee development, including 34.1 annual training hours per employee, and reproduces Deloitte Tohmatsu Sustainability's limited assurance report over selected sustainability data.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2020
Published
Oct 1, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees